TRL/Lp(a)-linked chemokine signature

There is 1 paper on TRL/Lp(a)-linked chemokine signature in aging research: 1 observational study in people.

Biomarker

1 paper studies it1 finding

See all 1 papers on TRL/Lp(a)-linked chemokine signature

“A specific chemokine signature linked to both TRL and Lp(a) accounted for around 40% (with wide confidence limits) of the TRL/remnant cholesterol: cardiovascular disease (CVD) association.”
A Chemokine Profile Linked to Both Triglyceride-Rich Lipoproteins and Lipoprotein(a), But Not LDL, Is Associated With Cardiovascular DiseaseJACC. Basic to translational science2026doi:10.1016/j.jacbts.2026.101736
  • Humans1

Effects

1

Cardiovascular disease

mediatesin humans1

1 study
  1. TRL/Lp(a)-linked chemokine signature is linked with cardiovascular disease in humans (TRL/remnant cholesterol–cardiovascular disease association) (Around 40% of the association, with wide confidence limits).

    HumansTRL/remnant cholesterol–cardiovascular disease associationn = 46,000

More on Cardiovascular disease

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 1Nov 2026: 01 paper in 12 months